OccuRx raises awareness of the importance of World Diabetes Day

Melbourne, Australia, 14 November 2022: OccuRx, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic diseases, raises awareness of World Diabetes Day (WDD).

WDD is the world’s largest diabetes awareness campaign reaching a global audience of over 1 billion people in more than 160 countries. The campaign draws attention to issues of paramount importance to the diabetes world and keeps diabetes firmly in the public and political spotlight.

In 2022, the campaign focuses on the need for access to diabetes care and better access to quality diabetes education for healthcare professionals and people living with diabetes.

One in 10 adults around the world currently live with diabetes, an estimated 537 million people. Almost half do not know they have it.

Diabetes is a serious complex condition which can affect the entire body.  When someone has diabetes, their body is unable to maintain healthy levels of glucose in the blood. Unhealthy levels of glucose in the blood can lead to long-term and short-term health complications in organs such as the eyes, kidneys and heart. In fact, diabetes is the leading cause of blindness in working age adults and the leading cause of kidney failure and dialysis.

Diabetes also:

  • Increases the risk of heart attacks and stroke by up to four times
  • Is a major cause of limb amputations
  • Affects mental health as well as physical health. Depression, anxiety and distress occur in more than 30% of all people with diabetes

Early diagnosis, optimal treatment and effective ongoing support and management reduce the risk of diabetes-related complications.

Follow World Diabetes Day 2022 on the following channels:

“Today is an extremely important in increasing awareness around diabetes and its complications. We are proud to be developing innovative treatments in the hope to preserve kidney and ocular function, manage complications, and improve quality of life by addressing diabetic complications.” said Professor Darren Kelly, Executive Chair of OccuRx.